First‑in‑human study tests gamitrinib designed to disrupt cancer cells’ energy systems

Media coverage

• Title	First‑in‑human study tests gamitrinib designed to disrupt cancer cells’ energy systems
  Media name/outlet	EurekAlert!
  Country/Territory	United States
  Date	06/2/26
  URL	ct.moreover.com/?a=59681452670&p=1gw&v=1&x=zzh17jgmUHfLkUf63pVo-A
  Persons	Anthony J. Olszanski